Cancer Institute and Hospital, Chinese Academy of Medical Sciences: all 387 studies

Page 4 of 4. Open to participants first (275), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung CancerActive, not recruitingNCT06540950Phase 2
• An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course TreatmentActive, not recruitingNCT06501976Phase 2
• Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell LymphomaActive, not recruitingNCT06492629Phase 2
• Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTCActive, not recruitingNCT06490107Phase 2
• RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal AntibodyActive, not recruitingNCT06481553
• Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical CancerActive, not recruitingNCT06419673Phase 2
• Toripalimab for High-risk Locally Advanced Cervical CancerActive, not recruitingNCT06416696Phase 2
• Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC PatientsActive, not recruitingNCT06403709Phase 2
• Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal CancerCompletedNCT06293612
• HA-WBRT-SIB for Brain Metastasis of Lung CancerCompletedNCT06289023Phase 2
• Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor ThrombosisCompletedNCT06233981Phase 2
• Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete ResectionActive, not recruitingNCT06189183Not applicable
• Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast CancerStatus unknownNCT06156761Not applicable
• Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral ResectionCompletedNCT06115837
• A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node MetastasisCompletedNCT06048146Not applicable
• Tislelizumab Combined With Chemotherapy in First-line Treatment of AGCActive, not recruitingNCT06034964
• Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCCActive, not recruitingNCT05951127Not applicable
• Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)CompletedNCT05938374Phase 2
• Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLCActive, not recruitingNCT05888402Phase 2
• To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2Status unknownNCT05774171
• Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast CancerStatus unknownNCT05749016Phase 2
• Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerStatus unknownNCT05747326Phase 2
• Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast CancerStatus unknownNCT05747313Phase 1/2
• Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing the the Laparoscopic and Open ApproachesCompletedNCT05707598
• A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast CancerStatus unknownNCT05681728Phase 2
• The Influence of Treatment Position (Prone vs. Supine) on Whole Breast TargetStatus unknownNCT05609058Not applicable
• Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal CancerCompletedNCT05542680Not applicable
• Pembrolizumab Plus CRT Followed by Surgery in Upper ESCCStatus unknownNCT05541445Phase 1/2
• Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal AdenocarcinomaCompletedNCT05540145
• Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer SurgeryCompletedNCT05523960Not applicable
• A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic TherapyStatus unknownNCT05511051Phase 2
• Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric CancerStatus unknownNCT05497739Phase 2
• Multi-center Study of Deep Learning AI in Breast MassStatus unknownNCT05443672
• ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic TherapyCompletedNCT05392699Phase 1
• A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM PathwayStatus unknownNCT05331326Phase 2
• Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105Status unknownNCT05289726Phase 2
• Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast CancerCompletedNCT05283616Phase 3
• A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)CompletedNCT05254899Phase 2
• Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02）CompletedNCT05235100Phase 2
• Carbon Nanoparticles and Indocyanine Green for Sentinel Lymph Node Biopsy in Early Stage Cervical CancerStatus unknownNCT05167149Not applicable
• SBRT With DIBH for HCC After TACE and Lipiodol MarkingActive, not recruitingNCT05021250Not applicable
• Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese PatientsStatus unknownNCT05009017
• A Proof of Concept Study of Pan-cancer Early Detection by Liquid BiopsyCompletedNCT04972201
• Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC TreatmentStatus unknownNCT04970043Not applicable
• A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and OxaliplatinStatus unknownNCT04850040Phase 2
• Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecTStatus unknownNCT04822792
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal CancerCompletedNCT04821765Phase 2
• Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCCCompletedNCT04791176Phase 2
• Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma with PVTTTerminatedNCT04709380Phase 3
• To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung CancerCompletedNCT04671303Phase 2
• A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal CancerActive, not recruitingNCT04543695Phase 2
• A Prospective Study of Hypothyroidism After Radiotherapy for Breast CancerCompletedNCT04528225
• Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene MutationStatus unknownNCT04500717Phase 3
• Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLCStatus unknownNCT04500704Phase 3
• Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast CancerStatus unknownNCT04498793Phase 2
• Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic VinorelbineStatus unknownNCT04389073Phase 2
• Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer PatientsActive, not recruitingNCT04320979Phase 3
• Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04213937Phase 2
• A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal CancerCompletedNCT04207918Phase 2
• Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT04125849Not applicable
• Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial CarcinomaStatus unknownNCT04099589Phase 2
• Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast CancerStatus unknownNCT04068090
• Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical ResectionStatus unknownNCT03839550Phase 2
• Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast CancerStatus unknownNCT03775928Phase 2
• Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)Status unknownNCT03772496Not applicable
• Randomized Trial of Accelerated Partial Breast IrradiationCompletedNCT03583619Not applicable
• Accelerated Partial Breast Irradiation With IMRT in Early Breast CancerActive, not recruitingNCT03583580Not applicable
• Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular CarcinomaCompletedNCT03535259Phase 2
• A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal CancerStatus unknownNCT03392220Not applicable
• Daytime Variation of Complication in Gastric and Pancreatic SurgeryStatus unknownNCT03383562
• Perioperative Electroacupuncture for Gastric Cancer Patients After GastrectomyStatus unknownNCT03291574Not applicable
• Perioperative Electroacupuncture After OperationStatus unknownNCT03291561Not applicable
• A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）Status unknownNCT03137368Phase 3
• Application Software in Dosage Adjustment for Advanced Cancer Patients With PainStatus unknownNCT03016364Phase 1/2
• Translational Research on Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT03009253Not applicable
• Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung CancerStatus unknownNCT02992353Not applicable
• Apatinib for Advanced Non-squamous Head and Neck CancerStatus unknownNCT02989259Phase 2
• IORT Versus CCRT for Pancreatic CancerStatus unknownNCT02981641Not applicable
• The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck CancerStatus unknownNCT02943252Phase 2
• Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung CancerStatus unknownNCT02933294Not applicable
• Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder CancerCompletedNCT02861196Not applicable
• IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic CancerStatus unknownNCT02734680Not applicable
• Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFRStatus unknownNCT02691871Phase 1
• Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLCCompletedNCT02688036Phase 3
• Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative SurgeryCompletedNCT01413269Phase 3
• 30Gy Versus 40Gy Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After ChemotherapyCompletedNCT01156259Phase 3
• Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT01024712Phase 2

← Cancer Institute and Hospital, Chinese Academy of Medical Sciences overview and focus areas